172 related articles for article (PubMed ID: 7199587)
1. Treatment of hirsutism with spironolactone.
Cumming DC; Yang JC; Rebar RW; Yen SS
JAMA; 1982 Mar; 247(9):1295-8. PubMed ID: 7199587
[TBL] [Abstract][Full Text] [Related]
2. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone as a single agent for long-term therapy of hirsute patients.
Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
[TBL] [Abstract][Full Text] [Related]
4. A novel use of spironolactone: treatment of hirsutism.
Shapiro G; Evron S
J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.
Gökmen O; Senöz S; Gülekli B; Işik AZ
Gynecol Endocrinol; 1996 Aug; 10(4):249-55. PubMed ID: 8908525
[TBL] [Abstract][Full Text] [Related]
6. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome.
Evans DJ; Burke CW
J R Soc Med; 1986 Aug; 79(8):451-3. PubMed ID: 3761287
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and clinical effects of spironolactone in female hyperandrogenism.
Siegberg R; Ylöstalo P; Laatikainen T; Pelkonen R; Stenman UH
Arch Gynecol; 1987; 240(2):67-73. PubMed ID: 3566358
[TBL] [Abstract][Full Text] [Related]
9. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
[TBL] [Abstract][Full Text] [Related]
10. Anti-androgens in gynaecological practice.
Reed MJ; Franks S
Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):581-95. PubMed ID: 2976627
[TBL] [Abstract][Full Text] [Related]
11. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome.
Cullberg G; Hamberger L; Mattsson LA; Mobacken H; Samsioe G
Acta Obstet Gynecol Scand; 1985; 64(3):195-202. PubMed ID: 3160211
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone in the treatment of hirsutism.
Anttila L; Ruutiainen K; Erkkola R
Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
[TBL] [Abstract][Full Text] [Related]
13. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
15. [Hirsutism].
van Zuuren EJ; Pijl H
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
[TBL] [Abstract][Full Text] [Related]
16. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone in combination drug therapy for unresponsive hirsutism.
Pittaway DE; Maxson WS; Wentz AC
Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
[TBL] [Abstract][Full Text] [Related]
18. Hirsutism--a low dose spironolactone therapy.
Vĕtr M
Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
